Search
Thursday, April 24, 2014 ..:: Home ::.. Register   Login
 News - Latest Updates
News, posted on - Friday, April 26, 2013

Following the decision of General Assembley on March 13, 2013 and due to the re-orientation of research activities, ADI International Institute for Advancement of Drug Development GmbH will cease to exist in its present form and formally close by April, 30, 2013.

Professor Alexandra Delini-Stula, owner and manager of ADI, will, however, continue its activities as independent free lance consultant under the aegis of

DeliniA

Pharma R&D Consulting

Mittlerestrasse 2

4056 Basel, Switzerland

Email Delini-Stula@gmx.ch

As former ADI, Pharma R&D Consulting intends to provide expertise and support to clinical pre-and postmarketing projects in all CNS indications with particular emphasis on therapeutic outcomes investigations.

 


 Print   
Copyright 2008 by ADI International Institute   Terms Of Use   Privacy Statement
ADI